137 related articles for article (PubMed ID: 38663162)
41. Hormone replacement therapy and the risk of melanoma in post-menopausal women.
Hicks BM; Kristensen KB; Pedersen SA; Hölmich LR; Pottegård A
Hum Reprod; 2019 Dec; 34(12):2418-2429. PubMed ID: 31803923
[TBL] [Abstract][Full Text] [Related]
42. Health related quality of life after combined hormone replacement therapy: randomised controlled trial.
Welton AJ; Vickers MR; Kim J; Ford D; Lawton BA; MacLennan AH; Meredith SK; Martin J; Meade TW;
BMJ; 2008 Aug; 337():a1190. PubMed ID: 18719013
[TBL] [Abstract][Full Text] [Related]
43. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Hollenstein J; Massuger LF; Gaarenstroom KN; Mourits MJ; Verheijen RH; van Dorst EB; van der Putten H; van der Velden K; Boonstra H; Aaronson NK
J Clin Oncol; 2006 Aug; 24(22):3576-82. PubMed ID: 16877724
[TBL] [Abstract][Full Text] [Related]
44. Changes in attitudes, knowledge and hormone replacement therapy use: a comparative study in two random samples with 6-year interval.
Thunell L; Stadberg E; Milsom I; Mattsson LA
Acta Obstet Gynecol Scand; 2005 Apr; 84(4):395-401. PubMed ID: 15762973
[TBL] [Abstract][Full Text] [Related]
45. The safety of postoperative hormone replacement therapy in epithelial ovarian cancer patients in China.
Wen Y; Huang H; Huang H; Wu M; Shen K; Pan L
Climacteric; 2013 Dec; 16(6):673-81. PubMed ID: 23710587
[TBL] [Abstract][Full Text] [Related]
46. Bone health in women with premature ovarian insufficiency/early menopause: a 23-year longitudinal analysis.
Jones AR; Enticott J; Ebeling PR; Mishra GD; Teede HT; Vincent AJ
Hum Reprod; 2024 May; 39(5):1013-1022. PubMed ID: 38396142
[TBL] [Abstract][Full Text] [Related]
47. Hormone replacement therapy and health behavior in postmenopausal polio survivors.
Kalpakjian CZ; Riley BB; Quint EH; Tate DG
Maturitas; 2004 Aug; 48(4):398-410. PubMed ID: 15283932
[TBL] [Abstract][Full Text] [Related]
48. Comparison of soft tissue body composition in postmenopausal women with or without hormone replacement therapy considering the influence of reproductive history and lifestyle.
Dittmar M
Ann Hum Biol; 2001; 28(2):207-21. PubMed ID: 11293728
[TBL] [Abstract][Full Text] [Related]
49. Hormone replacement therapy after treatment for a gynaecological malignancy.
O'Donnell RL; Clement KM; Edmondson RJ
Curr Opin Obstet Gynecol; 2016 Feb; 28(1):32-41. PubMed ID: 26626038
[TBL] [Abstract][Full Text] [Related]
50. Hormone Replacement Therapy Prescription after Premature Surgical Menopause.
Garg N; Behbehani S; Kosiorek H; Wasson M
J Minim Invasive Gynecol; 2020; 27(7):1618-1623. PubMed ID: 32173578
[TBL] [Abstract][Full Text] [Related]
51. Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective study.
Vermeulen RFM; Beurden MV; Kieffer JM; Bleiker EMA; Valdimarsdottir HB; Massuger LFAG; Mourits MJE; Gaarenstroom KN; van Dorst EBL; van der Putten HWHM; Aaronson NK
Eur J Cancer; 2017 Oct; 84():159-167. PubMed ID: 28818705
[TBL] [Abstract][Full Text] [Related]
52. Menopausal symptoms and knowledge towards daily life and hormone replacement therapy among menopausal women in Bangkok.
Chaopotong P; Titapant V; Boriboonhirunsarn D
J Med Assoc Thai; 2005 Dec; 88(12):1768-74. PubMed ID: 16518972
[TBL] [Abstract][Full Text] [Related]
53. Hormone replacement therapy use and menopausal symptoms among women participating in a behavioral lifestyle intervention.
Boraz MA; Simkin-Silverman LR; Wing RR; Meilahn EN; Kuller LH
Prev Med; 2001 Aug; 33(2 Pt 1):108-14. PubMed ID: 11493043
[TBL] [Abstract][Full Text] [Related]
54. Ovarian survival after pelvic radiation: transposition until the age of 35 years.
Hoekman EJ; Knoester D; Peters AAW; Jansen FW; de Kroon CD; Hilders CGJM
Arch Gynecol Obstet; 2018 Nov; 298(5):1001-1007. PubMed ID: 30218184
[TBL] [Abstract][Full Text] [Related]
55. Hormone replacement therapy and cancer risks in perimenopausal women: A retrospective cohort study using a Japanese claims database.
Inayama Y; Mizuno K; Yamaguchi K; Hamanishi J; Takeuchi M; Egawa M; Mandai M; Kawakami K
J Obstet Gynaecol Res; 2023 Jul; 49(7):1805-1814. PubMed ID: 37029559
[TBL] [Abstract][Full Text] [Related]
56. Sexual function and quality of life in women with cervical cancer before radiotherapy: a pilot study.
Grion RC; Baccaro LF; Vaz AF; Costa-Paiva L; Conde DM; Pinto-Neto AM
Arch Gynecol Obstet; 2016 Apr; 293(4):879-86. PubMed ID: 26319157
[TBL] [Abstract][Full Text] [Related]
57. Hormone Replacement Therapy in Post-Menopause Hormone-Dependent Gynecological Cancer Patients: A Narrative Review.
Villa P; Bounous VE; Amar ID; Bernardini F; Giorgi M; Attianese D; Ferrero A; D'Oria M; Scambia G
J Clin Med; 2024 Mar; 13(5):. PubMed ID: 38592285
[TBL] [Abstract][Full Text] [Related]
58. Hormone replacement therapy - where are we now?
Langer RD; Hodis HN; Lobo RA; Allison MA
Climacteric; 2021 Feb; 24(1):3-10. PubMed ID: 33403881
[TBL] [Abstract][Full Text] [Related]
59. Has the impact of hormone replacement therapy on health-related quality of life been undervalued?
Tosteson AN; Gabriel SE; Kneeland TS; Moncur MM; Manganiello PD; Schiff I; Ettinger B; Melton LJ
J Womens Health Gend Based Med; 2000 Mar; 9(2):119-30. PubMed ID: 10746515
[TBL] [Abstract][Full Text] [Related]
60. Body composition and muscle performance during menopause and hormone replacement therapy.
Sipilä S
J Endocrinol Invest; 2003 Sep; 26(9):893-901. PubMed ID: 14964443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
